2019-11-28 09:37:56
Richard J. Procter Jay J. Dunsford, Philip J. Rushworth,[b] David G. Hulcoop, Richard A. Layfield, and Michael J. Ingleson*
The selective formation of carbon–carbon bonds is arguably the most important transformation in synthetic chemistry. Among the most widely used C@C bond forming reactions is the Suzuki–Miyaura (SM) cross coupling reaction, which is even utilized on large scale in industry. This powerful method couples a boron based organic nucleophile with an organic electrophile, typically catalyzed by Pd or Ni compounds. Recently, catalysts based on other metals, particularly less toxic metals (relative to Pd/Ni), for example, copper and iron (which has the lowest toxicity rating),[7] that offer alternative reactivity profiles, and/or reduced costs, have gained increasing attention. However, zinc-catalyzed SM reactions are, to the best of our knowledge, unknown. This is despite the attractive features of zinc which include: (i) low toxicity (in contrast to Ni compounds, zinc has the same low toxicity rating as iron), and (ii) relatively high abundance, thus zinc compounds are inexpensive and have low supply risk.
The use of stoichiometric organozinc reagents in coupling reactions is well established, particularly the Pd-catalyzed Negishi reaction.[9] More recently, stoichiometric organozinc reagents have been used in coupling reactions that do not require transition-metal catalysts.[10] Of specific relevance to this work is the coupling of arylboronic acids with benzyl bromides in the presence of excess Et2Zn (Scheme 1 a). The proposed mechanism involves a zinc cation activating benzyl bromides for SN2 substitution.[11] Diaryl zinc species have also been reacted with alkyl halides (including benzylic) to form C(sp2 )@C(sp3) bonds in the abscence of a catalyst, provided the reaction was carried out in weakly-coordinating aromatic solvents (Scheme 1 b).[12] These recent developments, although notable, all use stoichiometric (or super-stoichiometric) quantities of zinc reagents. The use of sub-stoichiometric zinc compounds in C@C coupling is extremely rare, with the only example, to the best of our knowledge, being the coupling of alkyl Grignard reagents with a–hydroxy ester triflates catalyzed by ZnCl2 (Scheme 1c).[13] We sought to develop a catalytic zinc cross-coupling reaction that uses arylboron nucleophiles. This requires an arylborate able to convert zinc halide by-products from cross-coupling back to arylzinc species that are effective for cross-coupling with organic electrophiles. Herein, we realize this goal using readily accessible arylborate nucleophiles derived from arylboronic acid pinacol esters, with ZnBr2 proving to be an effective catalyst for coupling these arylborates with benzyl halides.
Although neutral aryl boranes exchange aryl for alkyl on reaction with dialkylzinc reagents, in order to transmetallate to zinc halides, more strongly nucleophilic arylboranes are required.[16,17] Attempts using arylboronic esters activated by alk-oxides led to transfer of the alkoxide group to zinc in preference to the aryl group (see Figure S2). In contrast, the lithium borate, [tBuB(Pin)Ph]Li, 1 a, selectively and rapidly (<30 min for complete consumption of 1 a) transfers an aryl group to zinc dihalides (halide=Br or Cl) in ether solvents, as indicated by the formation of tert-butylboronic acid pinacol ester (tBuBPin) by NMR spectroscopy (no PhBPin is observed precluding Zn@tBu formation). An alternative pathway, rapid alkyl transfer from 1 a to form ZnBu species, followed by rapid reaction of these with ArylBPin to form Aryl@Zn species is precluded, based on the slow reaction between ZnEt2 and ArylBpin (<5% aryl transfer after 30 mins).
With an effective boron to ZnX2 transmetallating agent in hand, the transmetallation from boron to zinc in arene solvents was attempted, but it did not proceed significantly, since it was hindered by the low solubility of the aryl borate reagent and zinc halides. Arene solvents were essential in previous work on coupling stoichiometric Ar2Zn with alkyl halides, whereas in ether solvents, coupling was effectively
quenched. By performing the transmetallation in cyclopentyl methyl ether (CPME) and then replacing CPME with benzene, the arylzinc product reacted with 3-methoxybenzyl bromide (2 a) to generate the desired product (3 a) within 1 h at 208C.
Subsequently, we found that using 10 mol% of zinc dihalide both steps can be performed in CPME, with heating enabling the cross-coupling step (Scheme 2), albeit with a lower hetero/homo coupling ratio. In contrast, using ArylBPin/ZnEt2 mixtures with 2 a as the electrophile led to minimal C(sp2)@C(sp3) crosscoupling after 18 h at 60℃.
The transmetallation and cross-coupling steps in ether solvents were optimized using 4-fluorobenzyl bromide, 2 b (enabling quantitative in situ analysis by 19F NMR spectroscopy). This revealed that lower temperatures and other ether solvents resulted in high selectivity for heterocoupling (see Table 1). It is noteworthy that successful cross-coupling was observed using dioxane as the solvent (entry 3), whereas ZnPh2 effectively does not undergo cross-coupling with benzylbromides in dioxane, even at 608C over 18 h.[11] Although highly selective crosscoupling was observed in both dioxane and 2-MeTHF, 2-MeTHF was utilized for this study due to its superior safety profile. Control reactions were performed next to examine the possibility of trace-metal catalysis.[18] ZnBr2 obtained from multiple sources and of different purity (including 99.999% purity) produced similar coupling outcomes. When the reaction was performed without ZnBr2, no 3 b is formed, and only minor homocoupling (4 b) is observed (entry 6). Catalysis by trace copper or nickel impurities is disfavored on the basis of lower hetero-/homocoupling selectivity (entries 7 and 8). FeBr2 was examined, and significant heterocoupling was observed (entry 9). However, FeBr2 is precluded as a “trace metal catalyst” in this chemistry due to significant reactivity differences compared to ZnBr2 (e.g. FeBr2 is an effective catalyst for heter-ocoupling using 1 a and aryl Grignard reagents, whereas ZnBr2 does not couple aryl Grignard reagents with benzylbromides, see the Supporting information for further discussion). A Pd catalyst also gave high heterocoupling selectivity (entry 10).
However, in the coupling of 4-bromobenzylbromide (an electrophile containing both an aryl C@Br and benzylic C@Br bond) with 1 a, ZnBr2 selectively couples through the benzylic carbon. In contrast, under identical conditions Pd(PPh3)4 cross-couples through both the C(sp2)@Br and the C(sp3)@Br, thus precluding Pd impurities as the catalyst in this protocol (see Supporting Information). Finally, under these conditions MgBr2 led to no heterocoupling (entry 11). These results strongly support a zinc-catalyzed cross-coupling between 1 a and 2 b.
Optimization of the boron nucleophile also was explored briefly. When the n-butyl congener of t-butyl borate 1 a (Li[nBuB(Pin)Ph], 5) was used instead of 1 a, 3 b was cleanly formed, however, the reaction was slower than when 1 a was used (compare entries 4 and 12. In contrast, using the alternative phenyl source Na[BPh4] led to minimal conversion to 3 b after 18 h (<15% 3 b, see Supporting Information). Finally, 1.5 equivalents of 1 a was found to improve cross-coupling yields (lower equivalents of 1 a did not lead to full consumption of the electrophile). This zinc-catalyzed cross-coupling was compatible with electron-withdrawing and donating groups (Table 2). It was also tolerant of halide, CF3, OCF3, alkyl, ether, thioether and heteroaryl groups, with excellent heterocoupling selectivity through out.
Electron-withdrawing groups on the arylborate, for example, p-(OCF3), are compatible but result in a slower reaction (only 30% heterocoupling after 24 h), so they require longer reaction times. Although ketone and aldehyde functional groups proved to be incompatible, esters and acetals were both amenable to coupling. Benzyl chlorides reacted slower than the analogous bromides, while 28 benzyl electrophiles also reacted more slowly than 18 benzyl bromides, however, both are also viable substrates if longer reaction times are used. Bromodiphenylmethane and methylallyl bromide were also effectively cross-coupled, however, octylbromide and cycloheptylbromide were not amenable. The formation of 3 o was highly selective (>95%) with minimal products from cineor tele-substitution observed, indicating that an organometallic ipso-coupling process dominates.[10g] The observed scope is consistent with an SN2 mechanism, and the minor amounts of homocoupling observed (<5%) is attributed to a zinc-free reaction based on Table 1 entry 6. Radical scavengers such as 9,10-dihydroanthracene (used in zinc-mediated radical borylations),[19] and styrene (a scavenger used in radical reactions involving arylborates)[20] did not inhibit heterocoupling.
With a closed-shell mechanism favoured, and neutral diarylzinc reagents precluded as the active species (since ZnPh2 and 2 a do not cross-couple in dioxane),[11] the formation of anionic arylzincates from 1 a was explored in 2-MeTHF. Anionic zincates are more nucleophilic than Ar2Zn species, and are often more effective in the transfer of aryl groups to electrophiles; for example, [tBu2PhZn]Li cleanly arylates MeI. To assess for zincate formation, two equivalents of 1 a were reacted with ZnBr2 at 208C; in <10 mins tBuBPin had completely formed (by NMR spectroscopy) indicating transfer of two equivalents of phenyl to zinc (Scheme 3). The composition of the ensuing zincate species will most likely predominantly be of the form {[PhxZnBry]@}n (x+y=3, n=1 or higher aggregates), although only a single set of 1H and 13C phenyl resonances were observed, which is consistent with rapid exchange on the NMR timescale (as is the case throughout these experiments).[23] The zincate assignment is supported by significant changes in the 1H and 13C{1H} NMR spectra on addition of one equivalent of LiBr to ZnPh2, whereas a second equivalent of LiBr results in only very minor chemical-shift changes (indicating minimal formation of [PhxZnBry] 2@ {x+y=4} species).
To determine if an aryl group can be transferred from 1 a to a diarylzinc species, equimolar ZnPh2 and 1 a were reacted. This resulted in slow (at 208C) transfer to form [ZnPh3] @ (with a
diagnostic d 13C=168.8 for the ipso Cphenyl in 2-MeTHF) [24] and tBuBpin. At 608C approximately 2 h were required for formation of [ZnPh3] @ from ZnPh2 and 1 a. Li[ZnPh3], synthesized
from ZnPh2 and one equivalent of PhLi has a closely comparable d 13Cipso for the Zn@Ph moiety (169.5 ppm in 2-MeTHF).
Transmetallation from 1a to zinc species still proceeds in the presence of LiBr; for example, using a 1:2 mixture of ZnPh2/LiBr, 35% aryl transfer from 1 a to zinc occurs after 1 h at 608C, thus aryl transfer to {[PhxZnBry] @}n species does occur. Li[ZnPh3] only interacts weakly with 1 equivalent of LiBr (as indicated by very minor changes in the 1H and 13C NMR resonances, max. Dd=0.02 ppm; addition of a second equivalent of LiBr results in no observable Dd). As [Ar4Zn]2@ are documented, attempts to form [Ph4Zn]2@ using 1 a were explored. However, the addition of 1 a to [Ph3Zn]@ (made in situ) did not lead to any observable aryl transfer (by NMR spectroscopy) disfavoring formation of [Ph4Zn]2@ under these conditions. Attempts to crystallise these zincates failed; nevertheless, the above reactions indicate that a major Zn species present during catalysis is [ZnPh3]@. However, [PhxZnBry]n@ (x+y=3 or 4, n=1 or 2, y+1) will also be present, and will presumably increase in concentration as catalysis proceeds, due to the formation of LiBr as a by-product from cross-coupling along with consumption of 1a.
It is notable that combining 1 a and ZnX2 does not produce any observable [Ph4Zn]2@ in contrast to using PhLi. Therefore using borate 1 a allows [Ar3Zn]@ to be selectively accessed without any dianioic zincate formation. It is also notable that Na[BPh4] gives drastically different transmetallation outcomes to 1 a, since it does not transfer an aryl to ZnPh2 in 2-MeTHF (at 208C or 608C), and thus does not produce any observable [Ph3Zn]@. A relative nucleophilicity scale in 2-MeTHF for these nucleophiles is shown in Scheme 4, with 1 a uniquely positioned between the monoanionic triaryl and dianionic tetraaryl zincates.
The stoichiometric coupling reactivity of various zincates with 2 b was assessed to determine if any heterocoupling occurs (and the selectivity for heterocoupling). In each case, benzylbromide 2 b was combined with a zincate mixture containing a specific ratio; for example, ZnPhyBrx, generated by combining ZnPh2 (or ZnBr2) with PhLi (or 1 a) and LiBr. On combining [ZnPh4] 2@ (formed from PhLi and ZnPh2) and 2 b in 2-MeTHF, 2 b was consumed within 20 min at 258C. However, this led exclusively to the homocoupled product 4 b (Table 3, entry 1). Therefore, for selective heterocoupling, [Ar4Zn]2@
species have to be avoided, presumably since these are stronger reducing agents, and thus lead to single-electrontransfer reactivity. In contrast, [ZnPh3] @ (made from PhLi and ZnPh2) on combination with 2 b predominantly led to hetero-coupling (entry 2). Repeating in the presence of LiBr also led to formation of [ZnPh3]@(confirmed by comparable d 13C for the ipso Cphenyl, entry 4) and a comparable coupling outcome. Notably, a 1:1 mixture of 1 a/ZnPh2 (post heating at 608C for 18 h) when reacted with 2 b produced predominantly 3 b, with a slightly improved hetero/homo coupling ratio (entry 3 compared to 2, or 4), suggesting that tBuBPin may subtly affect the catalytic process and thus the overall selectivity. A number of mixed zincates, [PhxZnBry] n@(with d 13C resonances supporting the presence of Zn@Br moieties),[26] were reacted with 2 b; reactivity was slow at 608C, and either more 4 b was produced than 3 b (entry 5), or no reaction was observed at all (entry 6).
Therefore, the triarylzincates appear to be essential to lead to significant heterocoupling. This is consistent with the increased efficacy of 1.5 equivalents of 1 a relative to 1.1 equivalents in the catalysis, because otherwise low activity bromide–zincates will dominate as the reaction progresses. Previously, zinc Lewis acids were proposed to activate benzylbromides by coordination to bromide, thereby facilitating SN2 substitution by arylborates or zincates.[11] To assess if Lewis acids are present during catalysis, Et3PO was added (using the conditions from Table 1 entry 4) after 3 h. The 31P{1H} NMR spectrum showedadownfield shift of 12.44 ppm compared to free Et3PO, confirming that Lewis acidic species are present.
However, this may well be due to lithium Lewis acids, since a similar (Dd=13.98 ppm) downfield shift was observed upon addition of Et3PO to LiBr in 2-MeTHF. Furthermore, a 2:1 mixture of ZnPh2/1a was heated in 2-MeTHF until 1 a was consumed, targeting a 1:1 mixture of Lewis acidic ZnPh2 (solvent)n and zincate [ZnPh3]@. To this mixture, 2 b was added, and the reaction was heated to 608C for 1 h, leading to poor coupling selectivity (3 b/4 b of 2.8:1). Therefore, under these conditions, zinc Lewis acid mediated coupling is disfavoured, and a mechanism involving SN2 substitution by a triarylzincate is preferred, possibly involving substrate activation by Li+ salts.
In conclusion, benzyl halides can be coupled with aryl borates using ZnBr2 as catalyst. To the best of our knowledge this is the first zinc,catalyzed Suzuki–Miyaura reaction. Initial studies indicate an SN2 mechanism, with triarylzincates as the key nucleophiles. Our findings represent an advance in the development of less toxic, base-metal cross-coupling catalysts as alternatives to established methodologies using noble metals, and further investigations into the detailed mechanism and scope of the reaction are ongoing.
Acknowledgements
We acknowledge the ERC (Grant Number 305868) the EPSRC and GSK for financial support (Case award to RJP). Additional research data supporting this publication are available as Supporting Information accompanying this publication.
5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridinyl)methyl]thio-1H-benzimidazoleCatalog No.:AA0007VU CAS No.:102625-64-9 MDL No.:MFCD07368273 MF:C16H15F2N3O3S MW:367.3704 |
PantoprazoleCatalog No.:AA019FQG CAS No.:102625-70-7 MDL No.:MFCD00870182 MF:C16H15F2N3O4S MW:383.3698 |
5-Fluoroquinolin-3-olCatalog No.:AA0007W7 CAS No.:1026265-04-2 MDL No.:MFCD18414593 MF:C9H6FNO MW:163.1484 |
2-CHLORO-N-(THIOPHEN-2-YLMETHYL)QUINAZOLIN-4-AMINECatalog No.:AA019EX0 CAS No.:1026287-65-9 MDL No.:MFCD17348617 MF:C13H10ClN3S MW:275.7566 |
2-chloro-N,N-bis(2-methoxyethyl)acetamideCatalog No.:AA019HOO CAS No.:10263-25-9 MDL No.:MFCD03964600 MF:C8H16ClNO3 MW:209.6705 |
2-(2-Ethoxybenzamido)acetic acidCatalog No.:AA0007WT CAS No.:10263-57-7 MDL No.:MFCD00450166 MF:C11H13NO4 MW:223.2252 |
2-Chloro-n-(2-methoxyethyl)acetamideCatalog No.:AA0007WS CAS No.:10263-66-8 MDL No.:MFCD00996278 MF:C5H10ClNO2 MW:151.5914 |
2-Amino-n-(2,5-dimethylphenyl)benzamideCatalog No.:AA0007WE CAS No.:102630-80-8 MDL No.:MFCD01995805 MF:C15H16N2O MW:240.3003 |
2-AMINO-N-(3,4-DIMETHYLPHENYL)BENZAMIDECatalog No.:AA008T2R CAS No.:102630-81-9 MDL No.:MFCD00121517 MF:C15H16N2O MW:240.3003 |
3-Amino-n-(2,3-dimethylphenyl)benzamideCatalog No.:AA0007WD CAS No.:102630-86-4 MDL No.:MFCD03070710 MF:C15H16N2O MW:240.3003 |
Benzamide, 3-amino-N-(2,4-dimethylphenyl)-Catalog No.:AA0007WC CAS No.:102630-87-5 MDL No.:MFCD08691974 MF:C15H16N2O MW:240.3003 |
3-Amino-n-(3,4-dimethylphenyl)benzamideCatalog No.:AA0007WB CAS No.:102630-89-7 MDL No.:MFCD01138443 MF:C15H16N2O MW:240.3003 |
3-Amino-n-(3,5-dimethylphenyl)benzamideCatalog No.:AA0007WA CAS No.:102630-90-0 MDL No.:MFCD03166485 MF:C15H16N2O MW:240.3003 |
2-Fluoro-4-mercaptobenzoic acidCatalog No.:AA01BKHF CAS No.:1026347-56-7 MDL No.:MFCD12756691 MF:C7H5FO2S MW:172.1768 |
Telmisartan Related Compound B (15 mg) (4'-[(1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid)Catalog No.:AA008W54 CAS No.:1026353-20-7 MDL No.:MFCD09859646 MF:C33H30N4O2 MW:514.6169 |
Methyl 2-bromo-5-(trifluoromethyl)benzoateCatalog No.:AA0007WV CAS No.:1026355-57-6 MDL No.:MFCD09999461 MF:C9H6BrF3O2 MW:283.0419 |
CINPA1Catalog No.:AA01DZAO CAS No.:102636-74-8 MDL No.:MFCD00288296 MF:C23H29N3O3 MW:395.4947 |
1-Propanaminium, 3-carboxy-2-(4-carboxy-1-oxobutoxy)-N,N,N-trimethyl-, inner salt, (2R)-Catalog No.:AA0007X2 CAS No.:102636-82-8 MDL No.:MFCD16036250 MF:C12H21NO6 MW:275.2982 |
tert-Butyl 3-(aminomethyl)benzoateCatalog No.:AA0007WZ CAS No.:102638-45-9 MDL No.:MFCD08275208 MF:C12H17NO2 MW:207.2689 |
Butanamide, N-butyl-Catalog No.:AA0007XD CAS No.:10264-16-1 MDL No.:MFCD03367403 MF:C8H17NO MW:143.2267 |
N-Cyclohexyl-3-phenylpropanamideCatalog No.:AA0007Y7 CAS No.:10264-23-0 MDL No.:MFCD01358094 MF:C15H21NO MW:231.3333 |
3-isopropylcyclopentanoneCatalog No.:AA008ZY3 CAS No.:10264-56-9 MDL No.:MFCD17014644 MF:C8H14O MW:126.1962 |
2-Methoxymethyl-1h-imidazoleCatalog No.:AA0007XU CAS No.:102644-75-7 MDL No.:MFCD00082200 MF:C5H8N2O MW:112.1298 |
2,5-Dichloro-4-formylpyridineCatalog No.:AA0007XT CAS No.:102645-33-0 MDL No.:MFCD06410679 MF:C6H3Cl2NO MW:176.0001 |
2,5-DichloroisonicotinonitrileCatalog No.:AA0007XS CAS No.:102645-35-2 MDL No.:MFCD13185482 MF:C6H2Cl2N2 MW:172.9995 |
1-Naphthalenesulfonamide, 5-chloro-N-(6-phenylhexyl)-Catalog No.:AA0007XO CAS No.:102649-78-5 MDL No.:MFCD00065544 MF:C22H24ClNO2S MW:401.9495 |
1-Naphthalenesulfonamide, 5-chloro-N-heptyl-Catalog No.:AA0007XN CAS No.:102649-79-6 MDL No.:MFCD00065545 MF:C17H22ClNO2S MW:339.8801 |
Glycine, N-[(2S)-3-(4-aminophenyl)-2-[bis(carboxymethyl)amino]propyl]-N-[2-[bis(carboxymethyl)amino]ethyl]-Catalog No.:AA0007YO CAS No.:102650-29-3 MDL No.:MFCD20922757 MF:C21H30N4O10 MW:498.4837 |
1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acidCatalog No.:AA009QOP CAS No.:102650-30-6 MDL No.:MFCD20134095 MF:C22H28N4O10S MW:540.5435 |
1,2,3,4-Tetrahydronaphthalene-2-sulfonyl chlorideCatalog No.:AA01AJ8G CAS No.:102653-21-4 MDL No.:MFCD16671651 MF:C10H11ClO2S MW:230.7111 |
1-Amino-4-propylcyclohexaneCatalog No.:AA008WWF CAS No.:102653-37-2 MDL No.:MFCD11156904 MF:C9H19N MW:141.2539 |
2,4-Pyrimidinediamine, 5-[[4,5-dimethoxy-2-(1-methylethyl)phenyl]methyl]-Catalog No.:AA0007Z8 CAS No.:1026582-88-6 MDL No.:MFCD12828747 MF:C16H22N4O2 MW:302.3715 |
Pyridine, 2-chloro-6-(difluoromethyl)-Catalog No.:AA0007Z6 CAS No.:1026587-36-9 MDL No.:MFCD25368743 MF:C6H4ClF2N MW:163.5525 |
2-Bromo-4-isopropylthiazoleCatalog No.:AA0007Z5 CAS No.:1026598-63-9 MDL No.:MFCD12033481 MF:C6H8BrNS MW:206.1034 |
tert-Butyl 7-amino-5-azaspiro[2.4]heptane-5-carboxylateCatalog No.:AA01DUUL CAS No.:1026609-83-5 MDL No.:MFCD18375095 MF:C11H20N2O2 MW:212.2887 |
N,N',N''-Triphenyl-1,3,5-benzenetriamineCatalog No.:AA0007ZC CAS No.:102664-66-4 MDL No.:MFCD09863590 MF:C24H21N3 MW:351.4436 |
(S)-Piperidine-3-carboxamide hydrochlorideCatalog No.:AA0007Z1 CAS No.:1026661-43-7 MDL No.:MFCD22415259 MF:C6H13ClN2O MW:164.6332 |
2-amino-5-butylbenzonitrileCatalog No.:AA01DUUM CAS No.:1026684-22-9 MDL No.:MFCD24283924 MF:C11H14N2 MW:174.2423 |
(E)-N'-(2-cyanophenyl)-N,N-dimethylethenimidamideCatalog No.:AA00H9R9 CAS No.:102669-53-4 MDL No.:MFCD00994886 MF:C11H13N3 MW:187.2410 |
Labd-13-Ene-8,15-DiolCatalog No.:AA008Y8K CAS No.:10267-31-9 MDL No.:MFCD20274995 MF:C20H36O2 MW:308.4986 |
norcisaprideCatalog No.:AA008W7Y CAS No.:102671-04-5 MDL No.:MFCD28898457 MF:C22H27ClFN3O4 MW:451.9189 |
2-amino-4H,5H,6H-cyclopenta[d][1,3]thiazol-6-oneCatalog No.:AA01DUUN CAS No.:1026710-03-1 MDL No.:MFCD31665377 MF:C6H6N2OS MW:154.1896 |
N-CrotonylglycineCatalog No.:AA01CB6G CAS No.:1026721-15-2 MDL No.: MF:C6H9NO3 MW:143.1406 |
1-(4-Fluorobenzyl)pyrrolidine-2-carboxylic acidCatalog No.:AA01EK8M CAS No.:1026725-31-4 MDL No.:MFCD08444785 MF:C12H14FNO2 MW:223.2435 |
beta-D-Glucopyranuronic acid 1-(2-((benzyloxy)carbonyl)benzoate)Catalog No.:AA00978Q CAS No.:102674-29-3 MDL No.: MF:C21H20O10 MW:432.3775 |
4-(4-tert-butylphenyl)-2-{[(4-fluorophenyl)methyl]amino}-4-oxobutanoic acidCatalog No.:AA00IZLD CAS No.:1026751-55-2 MDL No.:MFCD00955022 MF:C21H24FNO3 MW:357.4186 |
IMatinib Para-diaMinoMethylbenzeneCatalog No.:AA008W6J CAS No.:1026753-54-7 MDL No.:MFCD30741278 MF:C29H31N7O MW:493.6027 |
Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-, hydrochloride (1:1)Catalog No.:AA000800 CAS No.:102676-31-3 MDL No.:MFCD00866239 MF:C14H14ClN3 MW:259.7341 |
FadrozoleCatalog No.:AA0007ZY CAS No.:102676-47-1 MDL No.:MFCD02313480 MF:C14H13N3 MW:223.2731 |
Methyl 3-(1-tritylimidazol-4-yl) propionateCatalog No.:AA0007ZX CAS No.:102676-60-8 MDL No.:MFCD04039625 MF:C26H24N2O2 MW:396.4810 |
3-(1-Tritylimidazol-4-yl) propionaldehydeCatalog No.:AA0007ZW CAS No.:102676-61-9 MDL No.:MFCD04039710 MF:C25H22N2O MW:366.4550 |
3-(4-ethylphenyl)-1H-pyrazole-5-carbohydrazideCatalog No.:AA01A0P0 CAS No.:1026764-45-3 MDL No.:MFCD02673707 MF:C12H14N4O MW:230.2658 |
1-(2,4-dimethoxybenzoyl)piperazine hydrochlorideCatalog No.:AA019W8Q CAS No.:1026767-54-3 MDL No.:MFCD12912950 MF:C13H19ClN2O3 MW:286.7546 |
N-[4-(Acetylamino)benzyl]-2-chloroacetamideCatalog No.:AA0007ZQ CAS No.:102677-62-3 MDL No.:MFCD00631544 MF:C11H13ClN2O2 MW:240.6861 |
3-(Aminomethyl)-4-methoxyaniline dihydrochlorideCatalog No.:AA0007ZP CAS No.:102677-73-6 MDL No.:MFCD03424318 MF:C8H14Cl2N2O MW:225.1156 |
3-AMINO-4-CHLORO-BENZENEMETHANAMINE DIHYDROCHLORIDECatalog No.:AA008T5B CAS No.:102677-74-7 MDL No.:MFCD03424326 MF:C7H11Cl3N2 MW:229.5346 |
N-(Phenylsulfonyl)-l-prolinamide hydrochlorideCatalog No.:AA01FPM7 CAS No.:1026778-29-9 MDL No.:MFCD31381786 MF:C11H15ClN2O3S MW:290.7664 |
Vx-222Catalog No.:AA008THT CAS No.:1026785-59-0 MDL No.:MFCD18089858 MF:C25H35NO4S MW:445.6147 |
Org-26576Catalog No.:AA01EO9A CAS No.:1026791-61-6 MDL No.:MFCD30738001 MF:C11H12N2O2 MW:204.2252 |
1-Methylpyrazole-4-boronic acid, HClCatalog No.:AA00080L CAS No.:1026796-02-0 MDL No.:MFCD09972098 MF:C4H8BClN2O2 MW:162.3825 |
Trifluoromethylthio-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzeneCatalog No.:AA008TY4 CAS No.:1026796-07-5 MDL No.:MFCD11042447 MF:C13H16BF3O2S MW:304.1361 |
2,5,7-Triazaspiro[3.4]octane-6,8-dione hydrochlorideCatalog No.:AA00H9RC CAS No.:1026796-27-9 MDL No.:MFCD20688617 MF:C5H8ClN3O2 MW:177.5889 |
4-Bromo-2-ethoxybenzotrifluorideCatalog No.:AA01A5UJ CAS No.:1026796-37-1 MDL No.:MFCD25371631 MF:C9H8BrF3O MW:269.0584 |
3-Bromo-6-fluoro-2-methoxyphenolCatalog No.:AA00080H CAS No.:1026796-50-8 MDL No.:MFCD12910488 MF:C7H6BrFO2 MW:221.0237 |
3-Ethenylazetidine-1-carboxylic acid tert-butyl esterCatalog No.:AA00080D CAS No.:1026796-78-0 MDL No.:MFCD16140212 MF:C10H17NO2 MW:183.2475 |
N-(4-Bromopyridin-2-yl)acetamideCatalog No.:AA00080C CAS No.:1026796-81-5 MDL No.:MFCD11976392 MF:C7H7BrN2O MW:215.0473 |
2-{4-[(difluoromethyl)sulfanyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolaneCatalog No.:AA01B8H4 CAS No.:1026796-82-6 MDL No.:MFCD22718112 MF:C13H17BF2O2S MW:286.1457 |
2-(2-Chlorophenyl)acetamideCatalog No.:AA00080Y CAS No.:10268-06-1 MDL No.:MFCD00176724 MF:C8H8ClNO MW:169.6082 |
Methyl 3-nitrophenylacetateCatalog No.:AA00080X CAS No.:10268-12-9 MDL No.:MFCD08669939 MF:C9H9NO4 MW:195.1721 |
N-(3,4-DiMethoxyphenylethyl)-4-nitrobenzaMideCatalog No.:AA00903X CAS No.:10268-50-5 MDL No.:MFCD00089141 MF:C17H18N2O5 MW:330.3352 |
Benzoic acid, 2-amino-, phenyl esterCatalog No.:AA00081M CAS No.:10268-69-6 MDL No.:MFCD00060603 MF:C13H11NO2 MW:213.2319 |
Benzoic acid, 4-amino-, phenyl esterCatalog No.:AA00081L CAS No.:10268-70-9 MDL No.:MFCD00189396 MF:C13H11NO2 MW:213.2319 |
N,N'-(1,3-Phenylene)diacetamideCatalog No.:AA00081I CAS No.:10268-78-7 MDL No.:MFCD00035792 MF:C10H12N2O2 MW:192.2145 |
N-(4-chlorobenzyl)-2,4-dinitroanilineCatalog No.:AA00940L CAS No.:10268-90-3 MDL No.:MFCD04124002 MF:C13H10ClN3O4 MW:307.6892 |
Benzoic acid, 4-[(1S)-1-hydroxyethyl]-, methyl esterCatalog No.:AA00081F CAS No.:102681-71-0 MDL No.:MFCD08702980 MF:C10H12O3 MW:180.2005 |
5-(4-chlorophenyl)-N-{[2-(2,2,2-trifluoroethoxy)pyridin-3-yl]methyl}pyridine-3-carboxamideCatalog No.:AA01C277 CAS No.:1026822-49-0 MDL No.:MFCD31592482 MF:C20H15ClF3N3O2 MW:421.8002 |
2-Bromo-5-(trifluoromethyl)benzaldehydeCatalog No.:AA000816 CAS No.:102684-91-3 MDL No.:MFCD04973760 MF:C8H4BrF3O MW:253.0160 |
1-(3-Bromoprop-1-yn-1-yl)-3-chlorobenzeneCatalog No.:AA01B7E4 CAS No.:1026840-30-1 MDL No.:MFCD22482457 MF:C9H6BrCl MW:229.5009 |
5-tert-Butyl 3-ethyl 4,6-dihydropyrrolo[3,4-c]pyrazole-3,5(1h)-dicarboxylateCatalog No.:AA00080Z CAS No.:1026853-23-5 MDL No.:MFCD12198788 MF:C13H19N3O4 MW:281.3077 |
6-Pyridin-4-ylpyrimidin-4-olCatalog No.:AA01FLVM CAS No.:1026857-25-9 MDL No.:MFCD16630185 MF:C9H7N3O MW:173.1714 |
4-chloro-8-fluoro-3-nitroquinolineCatalog No.:AA01B2P8 CAS No.:1026861-70-0 MDL No.:MFCD29048261 MF:C9H4ClFN2O2 MW:226.5917 |
2-(5-nitro-1H-pyrazol-1-yl)ethan-1-olCatalog No.:AA01DUUO CAS No.:1026867-48-0 MDL No.:MFCD31657892 MF:C5H7N3O3 MW:157.1274 |
Benzene, [(3,3,3-trifluoropropyl)thio]-Catalog No.:AA000813 CAS No.:102687-64-9 MDL No.:MFCD25371534 MF:C9H9F3S MW:206.2280 |
1-benzyl-3-iodo-1H-pyrazoleCatalog No.:AA01ABUO CAS No.:1026893-32-2 MDL No.:MFCD12756565 MF:C10H9IN2 MW:284.0963 |
3-BromobenzylamineCatalog No.:AA00082B CAS No.:10269-01-9 MDL No.:MFCD01026119 MF:C7H8BrN MW:186.0491 |
Bis(2-cyanoethyl)-N,N-diisopropyl phosphoramiditeCatalog No.:AA00081V CAS No.:102690-88-0 MDL No.:MFCD00797597 MF:C12H22N3O2P MW:271.2957 |
2-Cyanoethyl n,n,n',n'-tetraisopropylphosphorodiamiditeCatalog No.:AA00081T CAS No.:102691-36-1 MDL No.:MFCD00012213 MF:C15H32N3OP MW:301.4078 |
(S)-(+)-2-Methoxy-2-(1-naphthyl)propionic acidCatalog No.:AA00081S CAS No.:102691-93-0 MDL No.:MFCD03093634 MF:C14H14O3 MW:230.2592 |
2-methoxy-6-(methylsulfanyl)anilineCatalog No.:AA01C3ET CAS No.:1026915-82-1 MDL No.:MFCD20716846 MF:C8H11NOS MW:169.2440 |
4,4'-DifluorochalconeCatalog No.:AA008R15 CAS No.:102692-35-3 MDL No.:MFCD00219906 MF:C15H10F2O MW:244.2361 |
2-Propen-1-one, 1-(4-methylphenyl)-3-(4-nitrophenyl)-, (2E)-Catalog No.:AA00082R CAS No.:102692-40-0 MDL No.:MFCD00024800 MF:C16H13NO3 MW:267.2793 |
5-Fluoro-1-N-isopropylbenzene-1,2-diamineCatalog No.:AA00H9RN CAS No.:1026934-69-9 MDL No.:MFCD16744198 MF:C9H13FN2 MW:168.2113 |
rac Ketorolac 6-Benzoyl IsoMerCatalog No.:AA008VOM CAS No.:1026936-07-1 MDL No.:MFCD27978188 MF:C15H13NO3 MW:255.2686 |
3-Methyloct-7-en-2-olCatalog No.:AA01B5J8 CAS No.:1026951-50-7 MDL No.:MFCD20291751 MF:C9H18O MW:142.2386 |
(2E)-2-methyl-3-(thiophen-2-yl)prop-2-enoic acidCatalog No.:AA01ELYT CAS No.:102696-69-5 MDL No.:MFCD00092194 MF:C8H8O2S MW:168.2129 |
2-Propenoic acid, 3-(3-methyl-2-thienyl)-, (2E)-Catalog No.:AA00082L CAS No.:102696-70-8 MDL No.:MFCD00209366 MF:C8H8O2S MW:168.2129 |
3-(3-Thienyl)acrylic acidCatalog No.:AA00082K CAS No.:102696-71-9 MDL No.:MFCD00014535 MF:C7H6O2S MW:154.1863 |
6-Bromo-2-fluoro-3-(trifluoromethyl)benzoic acidCatalog No.:AA00082E CAS No.:1026962-68-4 MDL No.:MFCD21365092 MF:C8H3BrF4O2 MW:287.0058 |
4-Chloro-7-methoxy-3-nitroquinolineCatalog No.:AA0096AI CAS No.:1026963-05-2 MDL No.:MFCD17170303 MF:C10H7ClN2O3 MW:238.6272 |
8-bromo-6-methyl-3,4-dihydro-2H-1-benzopyran-4-oneCatalog No.:AA019WYD CAS No.:1026982-77-3 MDL No.:MFCD11104775 MF:C10H9BrO2 MW:241.0813 |
L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) esterCatalog No.:AA00082D CAS No.:1026987-94-9 MDL No.:MFCD28898588 MF:C23H40N2O9 MW:488.5717 |
2,3-Difluoro-4-iodoanilineCatalog No.:AA00H9RO CAS No.:1026989-94-5 MDL No.:MFCD21602052 MF:C6H4F2IN MW:255.0039 |
RuCl[(R,R)-Fsdpen](p-cymene)Catalog No.:AA00082C CAS No.:1026995-71-0 MDL No.:MFCD12545953 MF:C30H28ClF5N2O2RuS MW:712.1355 |
Chloro{[(1S,2S)-(-)-2-amino-1,2-diphenylethyl](pentafluorophenylsulfonyl)amido}(p-cymene)ruthenium(II)Catalog No.:AA008V2Q CAS No.:1026995-72-1 MDL No.:MFCD12545954 MF:C30H28ClF5N2O2RuS MW:712.1355 |
2-(Diethylamino)-n-mesitylacetamide hydrochlorideCatalog No.:AA00082Y CAS No.:1027-14-1 MDL No.:MFCD00425887 MF:C15H25ClN2O MW:284.8248 |
N-Acetyl-3,5-diiodo-L-tyrosineCatalog No.:AA00082W CAS No.:1027-28-7 MDL No.:MFCD09842134 MF:C11H11I2NO4 MW:475.0183 |
Ethyl 1-benzyl-4-oxo-pyrrolidine-3-carboxylateCatalog No.:AA00082U CAS No.:1027-35-6 MDL No.:MFCD09998956 MF:C14H17NO3 MW:247.2897 |
BIS(DIMETHYLAMINO)DIPHENYLSILANECatalog No.:AA008UR7 CAS No.:1027-62-9 MDL No.:MFCD00051540 MF:C16H22N2Si MW:270.4448 |
4-Piperidinecarboxamide, 4-(ethylamino)-1-(phenylmethyl)-Catalog No.:AA00083P CAS No.:1027-91-4 MDL No.:MFCD00023758 MF:C15H23N3O MW:261.3626 |
H-Dab(boc)-OHCatalog No.:AA00083E CAS No.:10270-94-7 MDL No.:MFCD00236842 MF:C9H18N2O4 MW:218.2502 |
6-Chloro-2-ethylbenzoxazoleCatalog No.:AA000837 CAS No.:1027019-12-0 MDL No.:MFCD21641331 MF:C9H8ClNO MW:181.6189 |
2,6-Dimethyl-4-chlorophenylboronic acidCatalog No.:AA000836 CAS No.:1027045-31-3 MDL No.:MFCD10566594 MF:C8H10BClO2 MW:184.4278 |
Methyl 7-methoxy-2,2-diphenylbenzo[d][1,3]dioxole-5-carboxylateCatalog No.:AA000838 CAS No.:102706-14-9 MDL No.:MFCD00183318 MF:C22H18O5 MW:362.3753 |
3-[3-(benzyloxy)phenyl]propanenitrileCatalog No.:AA01BE8F CAS No.:1027082-48-9 MDL No.:MFCD22003067 MF:C16H15NO MW:237.2964 |
3-phenylfuran-2-carbonitrileCatalog No.:AA01BEEK CAS No.:1027085-03-5 MDL No.:MFCD28118345 MF:C11H7NO MW:169.1794 |
2-(Ethylthio)-1-phenylethanoneCatalog No.:AA00084A CAS No.:10271-55-3 MDL No.:MFCD00026975 MF:C10H12OS MW:180.2667 |
2-(1,2-Thiazol-5-yl)acetic acidCatalog No.:AA01ADYG CAS No.:10271-84-8 MDL No.:MFCD19228414 MF:C5H5NO2S MW:143.1637 |
Isothiazole-5-carboxylic acidCatalog No.:AA000845 CAS No.:10271-85-9 MDL No.:MFCD07369964 MF:C4H3NO2S MW:129.1371 |
2-(1,2-Thiazol-4-yl)acetic acidCatalog No.:AA000841 CAS No.:10271-93-9 MDL No.:MFCD19228413 MF:C5H5NO2S MW:143.1637 |
Benzonitrile, 4,5-dimethoxy-2-nitro-Catalog No.:AA00084W CAS No.:102714-71-6 MDL No.:MFCD00017564 MF:C9H8N2O4 MW:208.1708 |
N1-(1-methoxypropan-2-yl)benzene-1,2-diamineCatalog No.:AA01BH3X CAS No.:1027156-38-2 MDL No.:MFCD11187063 MF:C10H16N2O MW:180.2468 |
5-butylimidazolidine-2,4-dioneCatalog No.:AA019XN6 CAS No.:102716-78-9 MDL No.:MFCD01851049 MF:C7H12N2O2 MW:156.1824 |
1,3-Benzenediacetonitrile, 5-(dibromomethyl)-α1,α1,α3,α3-tetramethyl-Catalog No.:AA00084I CAS No.:1027160-12-8 MDL No.:MFCD21363444 MF:C15H16Br2N2 MW:384.1089 |
2-Bromo-5-chlorothiazole-4-carboxylic acidCatalog No.:AA018MMY CAS No.:1027169-53-4 MDL No.:MFCD16615256 MF:C4HBrClNO2S MW:242.4782 |
β-D-Mannopyranoside, 4-nitrophenyl 4,6-O-cyclohexylidene-Catalog No.:AA00084T CAS No.:102717-16-8 MDL No.:MFCD04039645 MF:C18H23NO8 MW:381.3771 |
p-Nitrophenyl 3-O-Benzoyl-4,6-cyclohexylidene--D-mannopyranosideCatalog No.:AA008SKU CAS No.:102717-17-9 MDL No.:MFCD04039638 MF:C25H27NO9 MW:485.4832 |
2(3H)-Furanone, 5-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]dihydro-, (5S)-Catalog No.:AA00084S CAS No.:102717-29-3 MDL No.:MFCD09955150 MF:C21H26O3Si MW:354.5148 |
4(1H)-Quinolinone, 7-amino-Catalog No.:AA00084H CAS No.:1027189-62-3 MDL No.:MFCD09261103 MF:C9H8N2O MW:160.1726 |
3-Chloro-5-methoxyanilineCatalog No.:AA000852 CAS No.:10272-06-7 MDL No.:MFCD11035922 MF:C7H8ClNO MW:157.5975 |
3,5-DimethoxyanilineCatalog No.:AA000851 CAS No.:10272-07-8 MDL No.:MFCD00008392 MF:C8H11NO2 MW:153.1784 |
4-Phenylpiperidine hydrochlorideCatalog No.:AA00084Z CAS No.:10272-49-8 MDL No.:MFCD01632527 MF:C11H16ClN MW:197.7044 |
1-Methyl-4-phenylpiperidine hydrochlorideCatalog No.:AA01EQJA CAS No.:10272-50-1 MDL No.:MFCD00465368 MF:C12H18ClN MW:211.7310 |
1-(morpholin-4-yl)-2-nitroethen-1-amineCatalog No.:AA019XR3 CAS No.:102721-72-2 MDL No.:MFCD08444226 MF:C6H11N3O3 MW:173.1698 |
4-phenyl-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carbothioamideCatalog No.:AA00ITF9 CAS No.:1027224-91-4 MDL No.:MFCD01567615 MF:C18H18F3N3OS MW:381.4152 |
2-bromo-4h,5h,6h,7h,8h-cyclohepta[d][1,3]thiazoleCatalog No.:AA01DTCJ CAS No.:1027247-69-3 MDL No.:MFCD22035212 MF:C8H10BrNS MW:232.1407 |
6-Nitro-1h-indazol-3-amineCatalog No.:AA000854 CAS No.:1027259-01-3 MDL No.:MFCD11707246 MF:C7H6N4O2 MW:178.1481 |
4-chloro-N-cyclopropyl-3-nitrobenzene-1-sulfonamideCatalog No.:AA00IUWT CAS No.:1027272-32-7 MDL No.:MFCD02662337 MF:C9H9ClN2O4S MW:276.6968 |
2-((2-Amino-6-oxo-1H-purin-9(6H)-yl)methoxy)ethyl acetateCatalog No.:AA00085D CAS No.:102728-64-3 MDL No.:MFCD00871663 MF:C10H13N5O4 MW:267.2413 |
Dibenzyl(3-methoxypropyl)amineCatalog No.:AA00948D CAS No.:1027280-73-4 MDL No.:MFCD24448801 MF:C18H23NO MW:269.3813 |
3-Methyl-2-phenylpyridineCatalog No.:AA00085J CAS No.:10273-90-2 MDL No.:MFCD00006283 MF:C12H11N MW:169.2224 |
4H-Pyrrolo[3,2-d]pyrimidin-4-one, 2-amino-1,5-dihydro-7-β-D-ribofuranosyl-Catalog No.:AA000857 CAS No.:102731-45-3 MDL No.:MFCD00900594 MF:C11H14N4O5 MW:282.2527 |
2-(1H-Pyrazol-3-yl)acetic acidCatalog No.:AA00086G CAS No.:102732-63-8 MDL No.:MFCD03161180 MF:C5H6N2O2 MW:126.1133 |
A-943931Catalog No.:AA008Y6S CAS No.:1027330-97-7 MDL No.:MFCD25371543 MF:C17H21N5 MW:295.3821 |
1-(aminomethyl)cyclopentane-1-carboxamideCatalog No.:AA018S9T CAS No.:1027337-88-7 MDL No.:MFCD16118413 MF:C7H14N2O MW:142.1989 |
3-Hydroxy-1,2:5,6-dibenzocyclooct-7-yneCatalog No.:AA000863 CAS No.:1027338-06-2 MDL No.:MFCD10699137 MF:C16H12O MW:220.2659 |
tert-Butyl 1-(aminomethyl)cyclopropylcarbamateCatalog No.:AA000862 CAS No.:1027338-34-6 MDL No.:MFCD12404931 MF:C9H18N2O2 MW:186.2514 |
4-Fluoro-3-(trifluoromethylsulfonyl)benzenesulfonyl chlorideCatalog No.:AA00085Y CAS No.:1027345-07-8 MDL No.:MFCD16883063 MF:C7H3ClF4O4S2 MW:326.6729 |
4-Fluoro-3-(trifluoromethylsulfonyl)benzenesulfonamideCatalog No.:AA00085X CAS No.:1027345-08-9 MDL No.:MFCD16251392 MF:C7H5F4NO4S2 MW:307.2425 |
tert-Butyl 3-(n-benzyl-n-methylamino) piperidine-1-carboxylateCatalog No.:AA00H9RV CAS No.:1027345-51-2 MDL No.:MFCD16620821 MF:C18H28N2O2 MW:304.4271 |
L-CyclopropylalanineCatalog No.:AA00086C CAS No.:102735-53-5 MDL No.:MFCD00798687 MF:C6H11NO2 MW:129.1570 |
5-Chloro-1h-indazole-3-carbaldehydeCatalog No.:AA00086A CAS No.:102735-84-2 MDL No.:MFCD07781535 MF:C8H5ClN2O MW:180.5911 |
Benzene, 5-fluoro-2-methyl-1,3-dinitro-Catalog No.:AA000868 CAS No.:102735-88-6 MDL No.:MFCD11007947 MF:C7H5FN2O4 MW:200.1240 |
(5-Chloro-1H-indazol-3-yl)methanolCatalog No.:AA000866 CAS No.:102735-90-0 MDL No.:MFCD11707247 MF:C8H7ClN2O MW:182.6070 |
2-Bromo-4-(tert-butyl)-6-nitroanilineCatalog No.:AA00085T CAS No.:1027356-55-3 MDL No.:MFCD11845936 MF:C10H13BrN2O2 MW:273.1264 |
2,5-Dioxopyrrolidin-1-yl 3-methoxypropanoateCatalog No.:AA019E89 CAS No.:1027371-75-0 MDL No.:MFCD20229579 MF:C8H11NO5 MW:201.1766 |
1-(4-Methylpyrimidin-2-yl)thioureaCatalog No.:AA00M5IZ CAS No.:102739-58-2 MDL No.:MFCD15525460 MF:C6H8N4S MW:168.2195 |
2,3,3-trichloroprop-2-en-1-amine hydrochlorideCatalog No.:AA01BGHR CAS No.:10274-29-0 MDL No.:MFCD28125168 MF:C3H5Cl4N MW:196.8905 |
17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1αCatalog No.:AA008SO8 CAS No.:1027401-98-4 MDL No.:MFCD05863947 MF:C24H35F3O5 MW:460.5269 |
tert-Butyl n-(4-aminobutyl)-n-(benzyloxy)carbamateCatalog No.:AA01C1FZ CAS No.:1027408-37-2 MDL No.:MFCD24468686 MF:C16H26N2O3 MW:294.3892 |
H-Gln(trt)-ohCatalog No.:AA00086M CAS No.:102747-84-2 MDL No.:MFCD00237060 MF:C24H24N2O3 MW:388.4590 |
Benzeneethanamine, N,N-dimethyl-, hydrochloride (1:1)Catalog No.:AA00087U CAS No.:10275-21-5 MDL No.:MFCD00274037 MF:C10H16ClN MW:185.6937 |
2,7-Di-tert-butylnaphthaleneCatalog No.:AA00087T CAS No.:10275-58-8 MDL No.:MFCD00094397 MF:C18H24 MW:240.3832 |
Ethyl 6-bromopyrazolo[1,5-a]pyrimidine-3-carboxylateCatalog No.:AA00087Q CAS No.:1027511-41-6 MDL No.:MFCD10574908 MF:C9H8BrN3O2 MW:270.0827 |
1-Boc-2-butyl-piperazineCatalog No.:AA00087O CAS No.:1027511-69-8 MDL No.:MFCD08273959 MF:C13H26N2O2 MW:242.3577 |
1-((Benzyloxy)carbonyl)-3-((tert-butoxycarbonyl)amino)pyrrolidine-3-carboxylic acidCatalog No.:AA00087L CAS No.:1027511-76-7 MDL No.:MFCD09838931 MF:C18H23N2O6- MW:363.3850 |
1-Bromo-5-Fluoro-2-iodo-3-(trifluoromethyl)benzeneCatalog No.:AA008XKF CAS No.:1027511-93-8 MDL No.:MFCD09800680 MF:C7H2BrF4I MW:368.8929 |
4-Bromo-2-fluoro-5-methylphenylisothiocyanateCatalog No.:AA01FA4P CAS No.:1027512-10-2 MDL No.:MFCD09800684 MF:C8H5BrFNS MW:246.0994 |
4-Bromo-5-fluoro-2-methylphenylisothiocyanateCatalog No.:AA01FA4Q CAS No.:1027512-16-8 MDL No.:MFCD09800687 MF:C8H5BrFNS MW:246.0994 |
1-Boc-4-methylazepane-4-carboxylic acidCatalog No.:AA00087F CAS No.:1027512-23-7 MDL No.:MFCD10687157 MF:C13H22NO4- MW:256.3181 |
Pyrazine, 2-bromo-5-(1H-pyrrol-1-yl)-Catalog No.:AA00087E CAS No.:1027512-24-8 MDL No.:MFCD10688563 MF:C8H6BrN3 MW:224.0573 |
2-Chloro-3,5-dibromobenzotrifluorideCatalog No.:AA008XK9 CAS No.:1027512-27-1 MDL No.:MFCD09800690 MF:C7H2Br2ClF3 MW:338.3470 |
1-(5-bromopyrazin-2-yl)pyrrolidin-2-oneCatalog No.:AA01BBJ1 CAS No.:1027512-29-3 MDL No.:MFCD10688564 MF:C8H8BrN3O MW:242.0726 |
4-Carboxy-2-chlorophenylisothiocyanateCatalog No.:AA01FCFD CAS No.:1027512-44-2 MDL No.:MFCD09800695 MF:C8H4ClNO2S MW:213.6409 |
3-Carboxy-4-chlorophenylisothiocyanateCatalog No.:AA01FCFE CAS No.:1027512-49-7 MDL No.:MFCD09800696 MF:C8H4ClNO2S MW:213.6409 |
8-Fluoro-oxazolo[4,5-c]quinolineCatalog No.:AA00087D CAS No.:1027512-50-0 MDL No.:MFCD10687185 MF:C10H5FN2O MW:188.1579 |
2-Amino-3,5-dibromo-6-chlorobenzonitrileCatalog No.:AA01FBOK CAS No.:1027512-55-5 MDL No.:MFCD09800697 MF:C7H3Br2ClN2 MW:310.3731 |
1-Methylazepane-4-carboxylic acidCatalog No.:AA00H9RX CAS No.:1027512-62-4 MDL No.:MFCD10687192 MF:C8H15NO2 MW:157.2102 |
2-Amino-3,5-dibromo-4-fluorobenzoic acidCatalog No.:AA008XK6 CAS No.:1027512-91-9 MDL No.:MFCD09800711 MF:C7H4Br2FNO2 MW:312.9186 |
4-Carboxy-2-fluorophenylisothiocyanateCatalog No.:AA01FCFF CAS No.:1027512-94-2 MDL No.:MFCD09800712 MF:C8H4FNO2S MW:197.1863 |
4-Amino-3-bromo-5-fluorobenzoic acidCatalog No.:AA00087C CAS No.:1027512-98-6 MDL No.:MFCD09800713 MF:C7H5BrFNO2 MW:234.0225 |
3-Carboxy-4-fluorophenylisothiocyanateCatalog No.:AA01FCFG CAS No.:1027513-02-5 MDL No.:MFCD09800714 MF:C8H4FNO2S MW:197.1863 |
2,4-Dibromo-6-fluoro-3-(trifluoromethyl)anilineCatalog No.:AA00MH45 CAS No.:1027513-06-9 MDL No.:MFCD09800716 MF:C7H3Br2F4N MW:336.9070 |
3-Fluoro-5-(trifluoromethyl)phenyl isothiocyanateCatalog No.:AA01F2OB CAS No.:1027513-10-5 MDL No.:MFCD09800717 MF:C8H3F4NS MW:221.1747 |
3-Fluoro-5-iodobenzotrifluorideCatalog No.:AA00087B CAS No.:1027513-14-9 MDL No.:MFCD09800718 MF:C7H3F4I MW:289.9968 |
4-Ethoxycarbonyl-2-methylphenyl isothiocyanateCatalog No.:AA01F2W7 CAS No.:1027513-17-2 MDL No.:MFCD09800719 MF:C11H11NO2S MW:221.2755 |
4-Carboxy-2-methylphenylisothiocyanateCatalog No.:AA01FCFH CAS No.:1027513-23-0 MDL No.:MFCD09800720 MF:C9H7NO2S MW:193.2224 |
4-Methoxycarbonyl-2-chlorophenylisothiocyanateCatalog No.:AA01F9W4 CAS No.:1027513-26-3 MDL No.:MFCD09800721 MF:C9H6ClNO2S MW:227.6674 |
4-Methoxycarbonyl-2-fluorophenylisothiocyanateCatalog No.:AA01F9W5 CAS No.:1027513-36-5 MDL No.:MFCD09800725 MF:C9H6FNO2S MW:211.2128 |
4-Ethoxycarbonyl-2-fluorophenylisothiocyanateCatalog No.:AA01FA4S CAS No.:1027513-39-8 MDL No.:MFCD09800726 MF:C10H8FNO2S MW:225.2394 |
Ethyl 3-fluoro-4-iodobenzoateCatalog No.:AA01F6PL CAS No.:1027513-43-4 MDL No.:MFCD09800727 MF:C9H8FIO2 MW:294.0615 |
Methyl 3-fluoro-4-iodobenzoateCatalog No.:AA000879 CAS No.:1027513-46-7 MDL No.:MFCD09800728 MF:C8H6FIO2 MW:280.0349 |
3-Methoxycarbonyl-4-fluorophenylisothiocyanateCatalog No.:AA01F9W6 CAS No.:1027513-51-4 MDL No.:MFCD09800731 MF:C9H6FNO2S MW:211.2128 |
8-[4-[4-(4-Chlorobenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthineCatalog No.:AA008Y1M CAS No.:1027513-54-7 MDL No.:MFCD09971120 MF:C25H27ClN6O4S MW:543.0377 |
2-(3-Fluorophenyl)-4-methyl-1,3-thiazole-5-carboxylic acidCatalog No.:AA00H9RY CAS No.:1027513-59-2 MDL No.:MFCD09800735 MF:C11H8FNO2S MW:237.2501 |
2,4-DifluorobenzylisothiocyanateCatalog No.:AA01FEGF CAS No.:1027513-62-7 MDL No.:MFCD06740518 MF:C8H5F2NS MW:185.1938 |
2-Bromo-5-fluorophenyl isothiocyanateCatalog No.:AA008SF7 CAS No.:1027513-65-0 MDL No.:MFCD00276607 MF:C7H3BrFNS MW:232.0728 |
2-(Trifluoromethoxy)phenethyl isothiocyanateCatalog No.:AA01FAGC CAS No.:1027513-73-0 MDL No.:MFCD09800745 MF:C10H8F3NOS MW:247.2368 |
1-Bromo-2-(2,2,2-trifluoroethyl)benzeneCatalog No.:AA000878 CAS No.:1027513-81-0 MDL No.:MFCD09996898 MF:C8H6BrF3 MW:239.0324 |
3,5-Dichloro-4-fluorophenyl isothiocyanateCatalog No.:AA01FB26 CAS No.:1027513-82-1 MDL No.:MFCD09996902 MF:C7H2Cl2FNS MW:222.0669 |
2-(3-Chlorophenyl)-2,2-difluoroacetic acidCatalog No.:AA019XXG CAS No.:1027513-91-2 MDL No.:MFCD11007696 MF:C8H5ClF2O2 MW:206.5739 |
Ethyl 2,2-difluoro-2-(3-fluoro-4-methoxyphenyl)acetateCatalog No.:AA01F2KK CAS No.:1027513-96-7 MDL No.:MFCD11007698 MF:C11H11F3O3 MW:248.1984 |
difluoro(4-methoxyphenyl)acetic acidCatalog No.:AA008TLP CAS No.:1027513-97-8 MDL No.:MFCD11007700 MF:C9H8F2O3 MW:202.1548 |
2,2-difluoro-2-(3-methoxyphenyl)acetic acidCatalog No.:AA01BTOH CAS No.:1027513-99-0 MDL No.:MFCD11007703 MF:C9H8F2O3 MW:202.1548 |
Ethyl Difluoro-(4-methoxy-3,5-dimethylphenyl)-acetateCatalog No.:AA01F2GA CAS No.:1027514-03-9 MDL No.:MFCD11007705 MF:C13H16F2O3 MW:258.2611 |
Ethyl (4-Butylphenyl)difluoroacetateCatalog No.:AA01F3JY CAS No.:1027514-11-9 MDL No.:MFCD11007713 MF:C14H18F2O2 MW:256.2883 |
Ethyl4-(tert-Butyl)-alpha,alpha-difluorophenylacetateCatalog No.:AA01DEJ4 CAS No.:1027514-13-1 MDL No.:MFCD11007714 MF:C14H18F2O2 MW:256.2883 |
4-(tert-Butyl)-alpha,alpha-difluorophenylacetic AcidCatalog No.:AA01BU6B CAS No.:1027514-14-2 MDL No.:MFCD11007715 MF:C12H14F2O2 MW:228.2352 |
Ethyl (3,4-Dimethylphenyl)difluoroacetateCatalog No.:AA01F302 CAS No.:1027514-17-5 MDL No.:MFCD11007717 MF:C12H14F2O2 MW:228.2352 |
Ethyl 2-(3-chloro-4-fluorophenyl)-2,2-difluoroacetateCatalog No.:AA01F2MU CAS No.:1027514-18-6 MDL No.:MFCD11007718 MF:C10H8ClF3O2 MW:252.6175 |
2-(3-Chloro-4-fluorophenyl)-2,2-difluoroacetic acidCatalog No.:AA00P2BR CAS No.:1027514-19-7 MDL No.:MFCD11007719 MF:C8H4ClF3O2 MW:224.5644 |
2,2-Difluoro-2-(3-fluoro-4-methylphenyl)acetic acidCatalog No.:AA01F2PC CAS No.:1027514-20-0 MDL No.:MFCD11007720 MF:C9H7F3O2 MW:204.1459 |
Ethyl Difluoro-(3-fluoro-4-methylphenyl)acetateCatalog No.:AA01F2LW CAS No.:1027514-23-3 MDL No.:MFCD11007721 MF:C11H11F3O2 MW:232.1990 |
Ethyl 2,2-difluoro-2-(4-isopropylphenyl)acetateCatalog No.:AA01F321 CAS No.:1027514-27-7 MDL No.:MFCD11007725 MF:C13H16F2O2 MW:242.2617 |
2-Amino-3,5-dichloro-6-fluorobenzonitrileCatalog No.:AA01FBDF CAS No.:1027514-29-9 MDL No.:MFCD11007733 MF:C7H3Cl2FN2 MW:205.0165 |
3-(3-Methyl-5-isoxazolyl)-1-propanamineCatalog No.:AA01AQP6 CAS No.:1027518-85-9 MDL No.:MFCD16653020 MF:C7H12N2O MW:140.1830 |
Pyrazolo[1,5-a]pyrimidin-5(1H)-oneCatalog No.:AA000880 CAS No.:1027534-43-5 MDL No.:MFCD27989151 MF:C6H5N3O MW:135.1234 |
N,5-Dibenzyl-5-hydroxy-indole-3-glyoxylaMideCatalog No.:AA008WP9 CAS No.:102754-41-6 MDL No.:MFCD31562217 MF:C24H20N2O3 MW:384.4272 |
6-tert-Butyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acidCatalog No.:AA0093I3 CAS No.:1027546-34-4 MDL No.:MFCD12075247 MF:C14H15NO3 MW:245.2738 |
ethyl 1-(3-cyanophenyl)-1H-pyrazole-3-carboxylateCatalog No.:AA01BGAH CAS No.:1027551-30-9 MDL No.:MFCD28139385 MF:C13H11N3O2 MW:241.2453 |
4-Amino-1-tert-butyl-3-(2-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidineCatalog No.:AA00087Y CAS No.:1027572-46-8 MDL No.:MFCD16251181 MF:C15H17N5O MW:283.3284 |
Tri(t-butoxycarbonylethoxymethyl)ethanolCatalog No.:AA019DZW CAS No.:1027581-61-8 MDL No.:MFCD29042362 MF:C26H48O10 MW:520.6533 |
2,2-Dimethylbut-3-enoic acidCatalog No.:AA00088I CAS No.:10276-09-2 MDL No.:MFCD00196967 MF:C6H10O2 MW:114.1424 |
Isophorone oxideCatalog No.:AA00088G CAS No.:10276-21-8 MDL No.:MFCD00085465 MF:C9H14O2 MW:154.2063 |
tert-butyl 4-(5-iodopyrimidin-2-yl)piperazine-1-carboxylateCatalog No.:AA019END CAS No.:1027616-32-5 MDL No.:MFCD11977095 MF:C13H19IN4O2 MW:390.2200 |
2,2,2-Trifluoroethyl n-(propan-2-yl)carbamateCatalog No.:AA019V7F CAS No.:1027616-97-2 MDL No.:MFCD12197093 MF:C6H10F3NO2 MW:185.1443 |
2-Methyl-6,7-dihydro-2H-indazol-4(5H)-oneCatalog No.:AA00087X CAS No.:1027617-67-9 MDL No.:MFCD11847436 MF:C8H10N2O MW:150.1778 |
5-Cyclopropyl-3-(trifluoromethyl)-1h-pyrazoleCatalog No.:AA00087W CAS No.:1027617-86-2 MDL No.:MFCD03422575 MF:C7H7F3N2 MW:176.1391 |
Potassium benzyloxymethyltrifluoroborateCatalog No.:AA00088P CAS No.:1027642-25-6 MDL No.:MFCD11052815 MF:C8H9BF3KO MW:228.0610 |
Potassium (4-methoxy)benzyloxymethyltrifluoroborateCatalog No.:AA00088O CAS No.:1027642-26-7 MDL No.:MFCD11505925 MF:C9H11BF3KO2 MW:258.0869 |
Potassium (2-Trimethylsilyl)-ethoxymethyl trifluoroborateCatalog No.:AA00088N CAS No.:1027642-28-9 MDL No.:MFCD11505930 MF:C6H15BF3KOSi MW:238.1727 |
Potassium cyclopentoxymethyltrifluoroborateCatalog No.:AA00088M CAS No.:1027642-31-4 MDL No.:MFCD11505926 MF:C6H11BF3KO MW:206.0554 |
2-Chloro-n-(4-[ethyl(isopropyl)amino]phenyl)acetamide hydrochlorideCatalog No.:AA00VWHA CAS No.:1027643-27-1 MDL No.:MFCD08143663 MF:C13H20Cl2N2O MW:291.2167 |
2-(2-Pyrrolidinyl)-1,3-benzothiazole, HClCatalog No.:AA00088L CAS No.:1027643-30-6 MDL No.:MFCD04966888 MF:C11H13ClN2S MW:240.7523 |
(2S)-2-(2-oxopyrrolidin-1-yl)butanamideCatalog No.:AA00088Z CAS No.:102767-28-2 MDL No.:MFCD03265610 MF:C8H14N2O2 MW:170.2090 |
(S)-N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamideCatalog No.:AA00088Y CAS No.:102767-31-7 MDL No.:MFCD09955129 MF:C8H15ClN2O2 MW:206.6699 |
2-oxo-2-{4,7,7-trimethyl-3-oxobicyclo[2.2.1]heptan-2-yl}acetic acidCatalog No.:AA019MME CAS No.:10277-34-6 MDL No.:MFCD11836298 MF:C12H16O4 MW:224.2530 |
Nitric acid, lanthanum(3+) salt, hexahydrate (8CI,9CI)Catalog No.:AA000897 CAS No.:10277-43-7 MDL No.:MFCD00011067 MF:H12LaN3O15 MW:433.0119 |
Sulfuric acid, praseodymium(3+) salt (3:2)Catalog No.:AA000896 CAS No.:10277-44-8 MDL No.:MFCD00011177 MF:C6H20O12S3 MW:380.4108 |
(1R)-1-(1-benzothiophen-3-yl)ethan-1-amine hydrochlorideCatalog No.:AA01DUUP CAS No.:1027709-85-8 MDL No.:MFCD24415749 MF:C10H12ClNS MW:213.7270 |
2-Iodo-5-(trifluoromethyl)phenolCatalog No.:AA00089W CAS No.:102771-00-6 MDL No.:MFCD13186736 MF:C7H4F3IO MW:288.0057 |
Benzenamine, 4-(8-methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)-Catalog No.:AA00089V CAS No.:102771-26-6 MDL No.:MFCD00885518 MF:C17H15N3O2 MW:293.3199 |
5-(Trifluoromethoxy)pyridine-2-carboxylic acidCatalog No.:AA00089U CAS No.:102771-66-4 MDL No.:MFCD10697540 MF:C7H4F3NO3 MW:207.1068 |
Cis-1-tert-butyl 4-ethyl 3-phenylpiperidine-1,4-dicarboxylateCatalog No.:AA00089I CAS No.:1027710-05-9 MDL No.:MFCD27997363 MF:C19H27NO4 MW:333.4220 |
1-[[(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[[2-(1,1-diMethylethoxy)-1,1-diMethyl-2-oxoethoxy]iMino]acetyl]aMino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]Methyl]pyridiniuM Inner SaltCatalog No.:AA008WKP CAS No.:102772-66-7 MDL No.:MFCD21363485 MF:C26H30N6O7S2 MW:602.6824 |
tert-butyl [4-(S-methylsulfonimidoyl)phenyl]carbamateCatalog No.:AA01EILM CAS No.:1027730-26-2 MDL No.:MFCD31690028 MF:C12H18N2O3S MW:270.3479 |
(R)-5-Hydroxypiperidin-2-oneCatalog No.:AA00089M CAS No.:102774-92-5 MDL No.:MFCD06202375 MF:C5H9NO2 MW:115.1305 |
2-Benzyloxyphenylboronic acid, pinacol esterCatalog No.:AA00089E CAS No.:1027757-13-6 MDL No.:MFCD03001334 MF:C19H23BO3 MW:310.1951 |
1-(3-methylpyrazin-2-yl)ethan-1-amineCatalog No.:AA01BS2W CAS No.:1027763-60-5 MDL No.:MFCD26937645 MF:C7H11N3 MW:137.1823 |
1-(2'-Deoxy-2'-fluoro-a-L-arabinofuranosyl)-thymineCatalog No.:AA01EAWR CAS No.:1027764-72-2 MDL No.: MF: MW: |
4,7,8-trichloroquinazolineCatalog No.:AA01BF0T CAS No.:1027775-18-3 MDL No.:MFCD28118473 MF:C8H3Cl3N2 MW:233.4818 |
1-Pyrrolidinecarboxylic acid, 2-Methyl-4-oxo-, 1,1-diMethylethyl ester, (2R)-Catalog No.:AA00089C CAS No.:1027775-28-5 MDL No.:MFCD17212494 MF:C10H17NO3 MW:199.2469 |
methyl 5-(chloromethyl)-1,2-oxazole-4-carboxylateCatalog No.:AA01AHAN CAS No.:1027781-88-9 MDL No.:MFCD20547602 MF:C6H6ClNO3 MW:175.5697 |
6-Amino-5-bromopyridine-3-methanolCatalog No.:AA00089B CAS No.:1027785-19-8 MDL No.:MFCD16607035 MF:C6H7BrN2O MW:203.0366 |
6-Amino-5-bromo-pyridine-3-carbaldehydeCatalog No.:AA00089A CAS No.:1027785-21-2 MDL No.:MFCD16606540 MF:C6H5BrN2O MW:201.0207 |
tert-Butyl N-{1-[(4-fluorobenzene)sulfonyl]piperidin-4-yl}carbamateCatalog No.:AA00H9S5 CAS No.:1027785-44-9 MDL No.:MFCD26127213 MF:C16H23FN2O4S MW:358.4282 |
5-METHYLMYOSMINECatalog No.:AA008W5N CAS No.:102780-52-9 MDL No.:MFCD07369534 MF:C10H12N2 MW:160.2157 |
Decafluoro-2-trifluoromethyl-2-iodopentaneCatalog No.:AA007YGL CAS No.:102780-88-1 MDL No.:MFCD00082619 MF:C6F13I MW:445.9479 |
1-(pyridin-2-ylmethyl)piperidine-2-carboxylic acid dihydrochlorideCatalog No.:AA019VYD CAS No.:1027803-08-2 MDL No.:MFCD08543817 MF:C12H18Cl2N2O2 MW:293.1895 |
4-Chloro-5-iodo-2-(trifluoromethyl)pyridineCatalog No.:AA008WFG CAS No.:1027818-88-7 MDL No.:MFCD24369746 MF:C6H2ClF3IN MW:307.4395 |
5-Iodo-2-(trifluoromethyl)pyridin-4-olCatalog No.:AA008WFF CAS No.:1027818-89-8 MDL No.:MFCD24369747 MF:C6H3F3INO MW:288.9938 |
Dimethyl 4-iodo-1h-pyrazole-3,5-dicarboxylateCatalog No.:AA008XI6 CAS No.:1027819-68-6 MDL No.:MFCD08689740 MF:C7H7IN2O4 MW:310.0459 |
EPOXYPROPOXYPROPYL TERMINATED POLYDIMETHYLSILOXANECatalog No.:AA008UQY CAS No.:102782-97-8 MDL No.:MFCD00283171 MF: MW: |
EPOXYCYCLOHEXYLETHYL TERMINATED POLYDIMETHYLSILOXANE, 25-35csCatalog No.:AA008URL CAS No.:102782-98-9 MDL No.:MFCD00283171 MF: MW: |
(MERCAPTOPROPYL)METHYLSILOXANE - DIMETHYLSILOXANE COPOLYMERSCatalog No.:AA008RYG CAS No.:102783-03-9 MDL No.:MFCD00239549 MF:C7H20O2SSi2 MW:224.4685 |
4,5-Diamino-6-hydroxypyrimidine hemisulfateCatalog No.:AA008US8 CAS No.:102783-18-6 MDL No.:MFCD04118319 MF:C8H14N8O6S MW:350.3118 |
(2S)-2-amino-5-[(amino-dimethylamino-methylidene)amino]pentanoic acidCatalog No.:AA007J41 CAS No.:102783-24-4 MDL No.:MFCD00070085 MF:C8H18N4O2 MW:202.2541 |
2-Deoxy-α-D-ribose 1-phosphate bis(cyclohexylammonium) saltCatalog No.:AA007J3Z CAS No.:102783-28-8 MDL No.:MFCD00056072 MF:C17H37N2O7P MW:412.4586 |
2'-Deoxycytidine 5'-triphosphate disodium saltCatalog No.:AA00H9S6 CAS No.:102783-51-7 MDL No.:MFCD00084683 MF:C9H14N3Na2O13P3 MW:511.1206 |
2,3-Diphospho-D-glyceric acid pentasodium saltCatalog No.:AA003FI3 CAS No.:102783-53-9 MDL No.:MFCD00070074 MF:C3H3Na5O10P2 MW:375.9463 |
2'-Deoxyguanosine-5'-diphosphate disodium saltCatalog No.:AA00H9S7 CAS No.:102783-74-4 MDL No.:MFCD24369608 MF:C10H12N5Na3O10P2 MW:493.1466 |
1-Bromo-2-chloro-5-fluoro-4-nitrobenzeneCatalog No.:AA007J3Y CAS No.:1027833-17-5 MDL No.:MFCD11110551 MF:C6H2BrClFNO2 MW:254.4410 |
2-Methoxy-4-(trifluoromethyl)phenolCatalog No.:AA00H9S8 CAS No.:1027888-79-4 MDL No.:MFCD13185693 MF:C8H7F3O2 MW:192.1352 |
1-Amino-2-methylindoline, HClCatalog No.:AA00380C CAS No.:102789-79-7 MDL No.:MFCD03788266 MF:C9H13ClN2 MW:184.6659 |
2(1H)-Quinolinone, 6-(1H-pyrazol-1-yl)-Catalog No.:AA007YGE CAS No.:102791-46-8 MDL No.:MFCD09029679 MF:C12H9N3O MW:211.2194 |
4-(4-Methyl-1h-imidazol-1-yl)benzenamineCatalog No.:AA007YGD CAS No.:102791-87-7 MDL No.:MFCD09834629 MF:C10H11N3 MW:173.2144 |
tert-Butyl 4-(2-cyano-4-methylphenyl)piperazine-1-carboxylateCatalog No.:AA008688 CAS No.:1027911-78-9 MDL No.:MFCD17214276 MF:C17H23N3O2 MW:301.3834 |
2-(3-Methoxyphenyl)-N-propylacetamideCatalog No.:AA00H9SA CAS No.:1027924-71-5 MDL No.:MFCD19383381 MF:C12H17NO2 MW:207.2689 |
7-Fluoro-8-nitroquinazolin-4(3H)-oneCatalog No.:AA0096AJ CAS No.:1027929-81-2 MDL No.:MFCD30566227 MF:C8H4FN3O3 MW:209.1341 |
5-Fluoro-1,3-dimethyl-1H-pyrazole-4-carboxylic acidCatalog No.:AA019YIS CAS No.:1027991-91-8 MDL No.:MFCD20659165 MF:C6H7FN2O2 MW:158.1304 |
3-Benzyloxy-azetidine-1-carboxylic acid tert-butyl esterCatalog No.:AA0096SM CAS No.:1027995-71-6 MDL No.:MFCD09907653 MF:C15H21NO3 MW:263.3321 |
5-amino-2-(propan-2-yloxy)benzonitrileCatalog No.:AA01A1DB CAS No.:1027997-04-1 MDL No.:MFCD14607512 MF:C10H12N2O MW:176.2151 |
1-Hexyl-3,7-dimethyl-1H-purine-2,6(3H,7H)-dioneCatalog No.:AA003EHI CAS No.:1028-33-7 MDL No.:MFCD00041424 MF:C13H20N4O2 MW:264.3235 |
3-(4-Bromophenyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-oneCatalog No.:AA00867C CAS No.:1028-39-3 MDL No.:MFCD02046230 MF:C14H9BrN2OS MW:333.2031 |
3-(4-Chloro-phenyl)-2-mercapto-3h-quinazolin-4-oneCatalog No.:AA007J1D CAS No.:1028-40-6 MDL No.:MFCD02625653 MF:C14H9ClN2OS MW:288.7521 |
1-Isothiocyanato-1-methylcyclopropaneCatalog No.:AA01B9G1 CAS No.:1028018-36-1 MDL No.:MFCD02684164 MF:C5H7NS MW:113.1808 |
4-Desmethoxypropoxyl-4-methoxy RabeprazoleCatalog No.:AA008WW1 CAS No.:102804-77-3 MDL No.:MFCD09840358 MF:C15H15N3O2S MW:301.3635 |
2-[(4-METHOXY-3-METHYL-2-PYRIDINYL)-METHYLTHIO]-BENZIMIDAZOLECatalog No.:AA008WRW CAS No.:102804-82-0 MDL No.:MFCD08274753 MF:C15H15N3OS MW:285.3641 |
[D-P-CL-PHE(6),LEU(17)]-VASOACTIVE INTESTINAL PEPTIDE HUMAN, PORCINE, RATCatalog No.:AA008RPQ CAS No.:102805-45-8 MDL No.:MFCD00133956 MF:C148H239ClN44O42 MW:3342.2039 |
5-(Trifluoromethyl)-1h-imidazole-2-carbaldehydeCatalog No.:AA009S78 CAS No.:102808-02-6 MDL No.:MFCD10696737 MF:C5H3F3N2O MW:164.0853 |
PEG8-TosCatalog No.:AA019E78 CAS No.:1028089-05-5 MDL No.:MFCD30536162 MF:C21H36O10S MW:480.5695 |
2-(oxiran-2-yl)ethane-1-sulfonyl fluorideCatalog No.:AA01EJXT CAS No.:1028099-81-1 MDL No.:MFCD31616439 MF:C4H7FO3S MW:154.1600 |
2-(1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ylidene)hydrazinecarboxamideCatalog No.:AA00867U CAS No.:10281-41-1 MDL No.:MFCD00453968 MF:C11H19N3O MW:209.2881 |
2-((4-Fluorophenyl)sulfonyl)ethanamine hydrochlorideCatalog No.:AA009OPH CAS No.:1028126-98-8 MDL No.:MFCD08548471 MF:C8H10FNO2S MW:203.2339 |
2'-Deoxyguanosine 3'-monophosphate sodium saltCatalog No.:AA007YG7 CAS No.:102814-03-9 MDL No.:MFCD00057080 MF:C10H14N5NaO7P MW:370.2110 |
Uridine5'-(tetrahydrogen triphosphate), 2'-deoxy-, trisodium salt (9CI)Catalog No.:AA00H9SB CAS No.:102814-08-4 MDL No.:MFCD07189464 MF:C9H12N2Na3O14P3 MW:534.0872 |
(bis(2,2'-Bipyridine-N,N')triphenylphosphine)-4-aminobutyricacidrutheniumhexafluorophosphatecomplexCatalog No.:AA01ENME CAS No.:1028141-88-9 MDL No.:MFCD31382544 MF:C42H39F6N5O2P2Ru MW:922.7993 |
Propanamide,3-amino-N-(phenylmethyl)-3-thioxo-Catalog No.:AA007J3B CAS No.:102817-84-5 MDL No.:MFCD04606717 MF:C10H12N2OS MW:208.2801 |
4-PyrrolidiobenzonitrileCatalog No.:AA007J35 CAS No.:10282-30-1 MDL No.:MFCD07368512 MF:C11H12N2 MW:172.2264 |